Musi wa22 Gumiguru, nguva yekuMabvazuva,iyo US FDAyakabvumidzwa zviri pamutemo yeGiriyedhi antiviral Veklury (remdesivir) kuti ishandiswe muvakuru vane makore gumi nemaviri zvichikwira uye inorema ingangoita 40 kg inoda kurapwa muchipatara uye COVID-19. Sekureva kweFDA, Veklury parizvino ndiyo yega FDA-yakatenderwa COVID-19 kurapwa muUnited States.

Kukanganiswa nenhau idzi, migove yeGiriyedhi yakakwira 4.2% mushure memusika. Zvakakosha kuziva kuti VaTrump vakambotaura pachena kuti Remdesivir "mushonga wakakosha kuvarwere vari muchipatara vane coronary pneumonia" uye vakakurudzira FDA kuti ibvumidze mushonga uyu nekukurumidza. Mushure mekuonekwa kuti ane pneumonia nyowani, akabvumawo Remdesivir.

Maererano ne "Financial Times” mushumo, masayendisiti akaratidza kutyira kubvumirwa kwacho. Zvinhu zvakadai zviri kukonzerwa nenyaya yekuti sarudzo dzemutungamiri wenyika yeAmerica dzichaitwa mumasvondo maviri anotevera. Mvumo yeFDA inogona kunge iri nekuda kwekudzvinyirirwa kwezvematongerwo enyika, uye zvinodikanwa kuratidza hurumende Inopindura nedenda. Muna Chivabvu wegore rino, aimbove Mutungamiriri weAmerica, VaBarack Obama, vakashoropodza hutongi hwaTrump padambudziko idzva remabayo.“njodzi huru.“

Pamusoro pezvematongerwo enyika, pamusangano weWHO wenhaurirano yepneumonia nyowani muna Gumiguru 16, WHO Director-General Tedros vakati mhedzisiro ye "solidarity test" yakaratidza kuti remdesivir uye hydroxychloroquine, Lopinavir/ritonavir uye interferon kurapwa. zvinoita sezvisina zvazvinoita pahuwandu hwekufa kwemazuva makumi maviri nemasere kana kureba kwekugara kwechipatara muvarwere vari muchipatara. Muyedzo weWHO wakaratidza kuti Redecivir haishandemumatambudziko akaoma.301 ye2743 varwere vanorwara zvakanyanya muboka reRedecive vakafa, uye 303 ye2708 varwere vanorwara zvakanyanya muboka rekutonga vakafa; mwero wekufa waiva 11, zvichiteerana. % Uye 11.2%, uye mazuva makumi maviri nemasere ekufa kweRemdesivir neboka rekutonga zvakaputirana zvakanyanya, uye hapana mutsauko wakakura.

Asi mhedzisiro yekubatana uye mutual aid test isati yabuda,Gilead yakatumira kuti itenderwe muna August.

Mvumo yeRemdesivir yakavakirwa pamhedzisiro yemakiriniki matatu akasarudzika akadzorwa makiriniki ayo aisanganisira varwere vakaiswa muchipatara nekuda kwekuoma kweCCIDID-19. Muedzo wekiriniki wakaitwa neNational Institute of Allergy uye Utachiona hwezvirwere zvisina tsarukano, wakapetwa kaviri-mapofu, wakaitwa neNational Institute of Allergy and Infectious Diseases wakaongorora nguva yainotora varwere kuti vapore kubva kuCOVID-19 mukati memazuva makumi maviri nemapfumbamwe ekurapwa. Muyedzo uyu wakacherekedza varwere zana nemakumi matanhatu nevaviri vane hunyoro, vari pakati nepakati, uye vakakomba COVID-19 vakapinzwa muchipatara uye vakagamuchira remdesivir (541 vanhu) kana placebo (521 vanhu), pamwe nekurapwa kwakajairwa. Iyo yepakati nguva yekupora kubva kuCOVID-19 yaive mazuva gumi muboka remdesivir uye mazuva gumi nemashanu muboka re placebo, uye mutsauko waive wakakosha. Kazhinji, zvichienzaniswa neboka re placebo, mukana wekuvandudzwa kwekiriniki pazuva rechigumi neshanu muboka reRemdesivir waive wakakwira zvakanyanya.

Mukuru weFDA, Stephen Hahn, akataura kuti kubvumidzwa uku kunotsigirwa nedata kubva kune akawanda makiriniki miedzo iyo agency yakaongorora zvine hungwaru uye inomiririra yakakosha chiitiko chesainzi.r iyo korona itsva denda.